Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Assets: 2020-2024

Historic Assets for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $690.6 million.

  • Cellebrite DI's Assets rose 32.59% to $834.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $834.3 million, marking a year-over-year increase of 32.59%. This contributed to the annual value of $690.6 million for FY2024, which is 29.59% up from last year.
  • Per Cellebrite DI's latest filing, its Assets stood at $690.6 million for FY2024, which was up 29.59% from $532.9 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Assets registered a high of $690.6 million during FY2024, and its lowest value of $339.8 million during FY2021.
  • For the 3-year period, Cellebrite DI's Assets averaged around $542.2 million, with its median value being $532.9 million (2023).
  • Its Assets has fluctuated over the past 5 years, first decreased by 6.75% in 2021, then spiked by 32.13% in 2023.
  • Over the past 5 years, Cellebrite DI's Assets (Yearly) stood at $364.4 million in 2020, then declined by 6.75% to $339.8 million in 2021, then rose by 18.69% to $403.3 million in 2022, then soared by 32.13% to $532.9 million in 2023, then climbed by 29.59% to $690.6 million in 2024.